SGK-1 protects kidney cells against apoptosis induced by ceramide and TNF-α

D. Pastore, D. Della-Morte, A. Coppola, B. Capuani, M. F. Lombardo, F. Pacifici, F. Ferrelli, R. Arriga, C. Mammi, M. Federici, A. Bellia, N. Di Daniele, M. Tesauro, G. Donadel, D. Noto, P. Sbraccia, G. Sconocchia, D. Lauro

Research output: Contribution to journalArticle

12 Scopus citations

Abstract

Ceramide regulates several different cellular responses including mechanisms leading to apoptosis. Serum-and glucocorticoidinducible protein kinase (SGK)-1 is a serine threonine kinase, which activates survival pathways in response to stress stimuli. Recently, we demonstrated an anti-apoptotic role of SGK-1 in human umbilical endothelial cells treated with high glucose. In the present study, since ceramide induces apoptosis by multiple mechanisms in diabetes and its complication such as nephropathy, we aimed to investigate whether SGK-1 may protect even against apoptosis induced by ceramide in kidney cells. Human embryonic kidney (HEK)-293 cells stable transfected with SGK-1 wild type (SGK-1wt) and its dominant negative gene (SGK-1dn) have been used in this study. Apoptotic stimuli were induced by C2-ceramide and TNF-α to increase endogenous synthesis of ceramide. Upon activation with these stimuli, SGK-1wt transfected cells have a statistically significant reduction of apoptosis compared with SGK-1dn cells (P<0.001). This protection was dependent on activation of caspase-3 and Poly-ADP-ribosepolymerase-1 (PARP-1) cleavage. SGK-1 and AKT-1 two highly homologous kinases differently reacted to ceramide treatment, since SGK-1 increases in response to apoptotic stimulus while AKT-1 decreases. This enhancement of SGK-1 was dependent on p38-mitogen-activated-protein kinases (p38MAPK), cyclic-adenosine-monophosphate/protein kinase A (cAMP/PKA) and phosphoinositide-3-kinase (PI3K) pathways. Especially, by using selective LY294002 inhibitor, we demonstrated that the most involved pathway in the SGK-1 mediated process of protection was PI3K. Treatment with inhibitor of SGK-1 (GSK650394) significantly enhanced TNF-α-dependent apoptosis in HEK-293 cells overexpressing SGK-1wt. Caspase-3,-8 and-9 selective inhibitors confirmed that SGK-1 reduced the activation of caspase-dependent apoptosis, probably by both intrinsic and extrinsic pathways. In conclusion, we demonstrated that in kidney cells, overexpression of SGK-1 is protective against ceramide-induced apoptosis and the role of SGK-1 can be potentially explored as a therapeutic target in conditions like diabetes, where ceramide levels are increased.

Original languageEnglish (US)
Article numbere1890
JournalCell Death and Disease
Volume6
Issue number9
DOIs
StatePublished - Sep 17 2016

ASJC Scopus subject areas

  • Immunology
  • Cellular and Molecular Neuroscience
  • Cell Biology
  • Cancer Research

Fingerprint Dive into the research topics of 'SGK-1 protects kidney cells against apoptosis induced by ceramide and TNF-α'. Together they form a unique fingerprint.

  • Cite this

    Pastore, D., Della-Morte, D., Coppola, A., Capuani, B., Lombardo, M. F., Pacifici, F., Ferrelli, F., Arriga, R., Mammi, C., Federici, M., Bellia, A., Di Daniele, N., Tesauro, M., Donadel, G., Noto, D., Sbraccia, P., Sconocchia, G., & Lauro, D. (2016). SGK-1 protects kidney cells against apoptosis induced by ceramide and TNF-α. Cell Death and Disease, 6(9), [e1890]. https://doi.org/10.1038/cddis.2015.232